ArticleInternational journal of molecular sciences2024

ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response.

Richard D Lutze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.